Chemo Causes Nerve Pain For Many Cancer Patients
By Dennis Thompson HealthDay Reporter
WEDNESDAY, Jan. 29, 2025 -- Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review suggests.
These patients might experience loss of balance and coordination, weakness or sensations of numbness, tingling, “pins and needles,” or burning, researchers said in a study published Jan. 28 in the journal Regional Anesthesia & Pain Medicine.
“Our findings emphasize that chronic painful chemotherapy-induced peripheral neuropathy represents a substantial global health challenge, affecting more than 40% of those diagnosed,” concluded the research team led by Dr. Ryan D’Souza, an anesthesiologist with the Mayo Clinic in Rochester, Minn.
Platinum-based or taxane chemotherapy drugs appear to pose the greatest risk for nerve pain, and lung cancer patients seem to have the highest rates of neuropathy, results show.
Chemo drugs kill cancer but also damage healthy cells and tissues, including those of the nervous system, researchers said in background notes.
Peripheral neuropathy is a known potential side effect of chemotherapy, but this study is the first to estimate how common it is among cancer patients.
The condition is thought to be caused by chemo drug damage that disrupts or rewires normal nerve signaling, resulting in persistent pain, researchers said.
For the study, researchers pooled the results of 77 previous studies involving nearly 11,000 participants from 28 countries.
The data revealed that just over 41% of patients treated with chemo developed painful and persistent peripheral neuropathy that lasted at least three months.
Nearly 41% of patients treated with platinum-based chemo developed nerve pain, as well as just over 38% of those treated with taxanes, results show.
Nerve pain was most common in lung cancer patients, affecting more than 62%. This is probably because these patients frequently require multiple and prolonged cycles of chemo.
People treated for ovarian cancer (32%) and lymphoma (36%) had the lowest risk.
Researchers said future study should focus on how chemo specifically causes nerve pain, and on developing therapies that can protect cancer patients who are receiving the lifesaving treatment.
Sources
- BMJ Journals, news release, Jan. 28, 2025
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
NIH to Fund $10M in Long-Term Health Studies After Ohio Train Disaster
MONDAY, June 23, 2025 — The National Institutes of Health (NIH) will fund studies of the long-term health effects of a 2023 Ohio train derailment that released more than 1...
Appendix Cancer Cases Surge in Millennials and Gen X
TUESDAY, June 17, 2025 — When Chris Williams started feeling sharp stomach pain one night in 2021, he went straight to the emergency room. The next morning, he had surgery...
Blood Tests Can Detect Cancer Years Earlier
TUESDAY, June 10, 2025 — Blood tests can detect evidence of cancer three years earlier than the disease would otherwise be diagnosed, a new small-scale pilot study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.